OUTCOME OF CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA (APML) TREATED WITH SEQUENTIAL ARSENIC TRIOXIDE (ATO) AND ALL TRANS RETINOIC ACID (ATRA) BASED THERAPY: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTRE

被引：0
|
作者：
Panda, S. P. [1 ]
Pradhan, N. D. [1 ]
Shah, N. [1 ]
Prasad, M. [1 ]
Vora, T. [1 ]
Narula, G. [1 ]
Chinnaswamy, G. [1 ]
Subramanyam, P. G. [1 ]
Chougule, A. [1 ]
Amre, P. [2 ]
Arora, B. [1 ]
Kurkure, P. [1 ]
Banavali, S. D. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
[2] Tata Mem Hosp, Canc Cytogenet Lab, Bombay 400012, Maharashtra, India
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-129
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [21] Final Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 Trial: All-Trans Retinoic Acid (ATRA), Intravenous Arsenic Trioxide (ATO) and Idarubicin (IDA) As Initial Therapy for Acute Promyelocytic Leukemia (APL)
    Iland, Harry J.
    Collins, Marnie
    Hertzberg, Mark S.
    Seldon, Michael
    Grigg, Andrew P.
    Firkin, Frank
    Supple, Shane G.
    Campbell, Lynda J.
    Bradstock, Kenneth F.
    Seymour, John F.
    BLOOD, 2014, 124 (21)
  • [22] Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy
    Ghiaur, Alexandra
    Doran, Cristina
    Gaman, Mihnea-Alexandru
    Ionescu, Bogdan
    Tatic, Aurelia
    Cirstea, Mihaela
    Stancioaica, Maria Camelia
    Hirjan, Roxana
    Coriu, Daniel
    CANCERS, 2024, 16 (06)
  • [23] Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia
    Strocchio, Luisa
    Gurnari, Carmelo
    Santoro, Nicola
    Putti, Maria C.
    Micalizzi, Concetta
    Zecca, Marco
    Cuccurullo, Rosanna
    Girardi, Katia
    Diverio, Daniela
    Testi, Anna M.
    Lo-Coco, Francesco
    Locatelli, Franco
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 360 - 363
  • [24] An Outcome Analysis of Childhood Acute Promyelocytic Leukemia Treated with Atra and Arsenic Trioxide, and Limited Dose Anthracycline
    Naeem Jabbar
    Naema Khayyam
    Uzma Arshad
    Sidra Maqsood
    Syed Ahmer Hamid
    Neelum Mansoor
    Indian Journal of Hematology and Blood Transfusion, 2021, 37 : 569 - 575
  • [25] An Outcome Analysis of Childhood Acute Promyelocytic Leukemia Treated with Atra and Arsenic Trioxide, and Limited Dose Anthracycline
    Jabbar, Naeem
    Khayyam, Naema
    Arshad, Uzma
    Maqsood, Sidra
    Hamid, Syed Ahmer
    Mansoor, Neelum
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (04) : 569 - 575
  • [26] An Outcome Analysis of Childhood Acute Promyelocytic Leukemia Treated with Atra and Arsenic Trioxide, and Limited Dose Anthracycline
    Mansoor, N.
    Jabbar, N.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S193 - S193
  • [27] Epidemiology and outcomes of acute promyelocytic leukaemia in the era of all-trans retinoic acid (ATRA) chemotherapy and arsenic trioxide plus ATRA: a retrospective analysis
    Gill, Harinder
    Raghupathy, Radha
    Ni, Michael
    Xiao, Xiao
    Flores, Francis
    Lee, Carmen
    Yim, Rita
    Lee, Paul
    Kumana, Cyrus
    Kwong, Yok-Lam
    LANCET ONCOLOGY, 2022, 23 : S11 - S11
  • [28] EFFECTIVE ARSENIC TRIOXIDE/ALL-TRANS RETINOIC ACID (ATRA) REGIMEN WITHOUT CHEMOTHERAPY FOR PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    Zhu, K.
    Absalon, M.
    McMasters, R.
    Smolarek, T.
    Mo, J.
    Hess, L.
    Siekerman, M.
    Kumar, A.
    Siekerman, M.
    Phillips, C.
    O'Brien, M.
    Basu, M.
    Perentesis, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 74 - 74
  • [29] Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
    Xinxin Zhang
    Huiyun Zhang
    Limei Chen
    Mengchang Wang
    Jieying Xi
    Xin Liu
    Ming Xie
    Dengzhe Li
    Ekamjyot Singh Gulati
    Sha Gong
    Huaiyu Wang
    Trials, 19
  • [30] Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
    Zhang, Xinxin
    Zhang, Huiyun
    Chen, Limei
    Wang, Mengchang
    Xi, Jieying
    Liu, Xin
    Xie, Ming
    Li, Dengzhe
    Gulati, Ekamjyot Singh
    Gong, Sha
    Wang, Huaiyu
    TRIALS, 2018, 19
12345